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IT IS GENERALLY ACCEPTED that chemicallv
induced carcinogenesis is initiated by the
interaction either of the compound itself or
a reactive metabolite thereof, with nuclear
DNA leading to somatic mutation in the
target cells. Apart from a few direct-acting
compounds, most carcinogens in man's chem-
ical environment require metabolic activation
to exert their biological effects (Miller, 1970)
and animal studies have shown that species
sensitivity and the susceptibility of target
organs to a carcinogen can he influenced by
the dose, form and route of exposure, tissue
distribution, metabolic activation and detoxi-
fication processes, stability of reactive meta-
bolites formed and the receptivity of crucial
intracellular sites. Other factors known to
modulate the metabolic disposition of car-
cinogens are age, sex, strain, nutritional and
hormonal status and genetic deficiency
(Conney & Levin, 1974). Thus an under-
standing ofthe metabolic fate of a carcinogen
is bound to be of value in the extrapolation
of animal data to man.
Certain of these factors will be considered
in relation to the metabolic activation of
carcinogens in general, and of dimethylnitro-
samine and other N-nitrosamines in particu-
lar. Dimethylnitrosamiine (DMN), a potent
and versatile carcinogen in a wide range of
animal species, requires metabolic trans-
formation to exert its toxic and carcinogenic
effects (Magee & Barnes, 1967). Studies in
the rat and other animal species have shown
that DMN is rapidly metabolized in the intact
animal (Heath, 1962) and that the liver is the
principal organ involved in the bioactivation
of this nitrosamine (Magee & Vandekar,
1958). Investigations on liver preparations
have revealed that DMN degradation is
mediated by the microsomal fraction, and
that NADPH and molecular oxygen are
essential co-factor requirements (Venkatesan
et al., 1970). This finding has led to the con-
clusion that the bioactivation of DMN to
eletrophilic species is mediated by the hepatic
microsomal mixed-function oxidase (MFO)
system centred on cytochrome P-450.
However, an accumulating body of experi-
mental evidence indicates that the metabolic
activation process involved in DMN degrada-
tion may be more complex, and not mediated
solely by the MFO enzyme system. Earlier
studies had shown that pretreatment of
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animals with inducers of mixed function
oxidase (e.g., phenobarbitone, DDT or 20-
methylcholanthrene) contrary to expectation,
protected against DMN-induced liver necrosis
and tumorigenesis (Venkatesan et al., 1970;
McLean & Verschuuren, 1969).
Our investigations into the metabolism of
DMN in the intact rat and by liver prepara-
tions have revealed further important differ-
ences in respect ofthe exclusive participation
of the hepatic microsomal MFO complex in
the bioactivation of this carcinogen. In vitro
studies showed that DMN did not interact
with cytochrome P-450 to give a difference
spectrum characteristic ofMFO substrates, or
measurably inhibit the metabolism of typical
MFO substrates (Lake et al., 1976a). Further-
more, rat hepatic microsomal DMN dimethyl-
ase activity showed a remarkable degree of
stability in liver preparations stored at 4°C,
in contrast to cytochrome P-450-dependent
enzyme activities. Investigations into the
effects of model inhibitors on hepatic DMN
demethylase activity showed that SKF-525A
and metyrapone did not significantly inhibit,
whereas cyanide, azide, pyrazole and disul-
firam markedly inhibited the enzyme activity
at concentrations having little effect on the
activities of typical MFO enzymes (Lake
et al., 1976b). Additional studies showed that
the lathyrogenic compounds aminoacetoni-
trile and 3-propionitrile significantly in-
hibited DMN demethylase activity. This
tentative evidence indicating the possible
involvement of an N-oxidative step in the
enzymic degradation ofDMNreceived further
support from experimental findings with
model inhibitors and substrates of mono-
amine oxidase. A wide range of these com-
pounds, including indazole, benzothiazole,
isoxazole, pargyline, benzylamine and /3-
phenylethylamine were found profoundly to
inhibit hepatic DMN-demethylase activity at
concentrations showing minimal inhibitory
effects on typical MFO enzyme activities
(Lake et al., 1978). On the other hand,
diamines such as spermidine, cadaverine and
putrescine, or substrates of the microsomal
mixed-function amine-oxidase enzyme des-
cribed by Ziegler & Mitchell (1972) had little
effect onDMN-demethylase activity.
Studies conducted in the intact rat and by
the isolated-liver perfusion technique showed
that the inhibitors ofhepatic DMN demethyl-
ase also inhibited the metabolism of DMN
both in vivo and ex vivo (Phillips et al., 1978).
Additionallv, it was found that pyrazole
pretreatment protected against DMN-induced
liver injury in the rat (Phillips et al., 1977).
Investigations were carried out into the
effect of these inhibitors on the mutagenicity
ofDMN in the Ames test. The results showed
that all the compounds tested inhibited the
mutagenicity of DMN in a dose-related
manner. These findings showing that amino-
acetonitrile and disulfiram inhibit DMN
metabolism and mutagenicity are in line with
the reported protection afforded by these
compounds against the hepatocarcinogenic
effect of DMN (Hadjiolov, 1971; Schmahl
et al., 1976). It is conceivable, therefore, that
some ofthe other compounds found to inhibit
the in vitro and in vivo metabolism and
mutagenicity of DMN may also modify the
carcinogenicity of this nitrosamine. Studies
on diethylnitrosamine andnitrosopyrrolidine,
showing that the inhibitors of DMN meta-
bolism also inhibit the biodegradation ofthese
nitrosamines, suggest a common metabolic
step in their bioactivation (Cottrell et al.,
1979).
DMN and other N-nitrosamines are present
in trace amounts in the human diet and
constitute a potential carcinogenic hazard.
Biogenic amines shown to inhibit the meta-
bolism of DMN are also present in foods at
substantially higher levels. It is possible that
th-ese compounds may influence the metabolic
fate and biological activity of ingested nitro-
samines in man. Involvement of relevant
factors in modifying the carcinogenicity of
other environmental chemicals are discussed.
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A MAJOR BREAKTHROUGH towards an
understanding of the mechanism of action of
chemical carcinogens came with the recogni-
tion of the role of metabolism in the genera-
tion of a reactive species. Theories of car-
cinogenesis were forced to switch from con-
sideration of the nature of the applied
carcinogen to speculation on the nature of
the vital metabolite.
In the case ofmost carcinogens, very many
metabolic products could be recognized and
the problem was to determine which were
relevant to carcinogenesis.
Following the demonstration of a correla-
tion between the carcinogenic potency and
the extent of DNA reaction in the skin of
mice for a series of polycyclic hydrocarbons,
it was postulated that DNA modification was
the vital event for initiation of tumours.
Subsequent studies from many laboratories
with a variety of chemical carcinogens have
supported this hypothesis, and much time
and effort have been devoted to identifying
the DNA products.
It became clear that not all DNA reaction
products were equally important in relation
to initiation. In particular, studies with the
simple alkylating carcinogens implicated
quantitatively minor products of DNA
reaction, namely those involving attack on
the oxygen atoms of the bases. Such reaction
products, and in particular 06-alkylguanines,
had been clearly implicated as being respon-
sible for the induction of mutation in simple
bacteriophage systems. The close relationship
between mutagenesis and carcinogenesis was
subsequently established for many classes of
carcinogen.
In the case of polycyclic hydrocarbons it
proved unexpectedly difficult to determine
the nature of the in vivo DNA-bound form of
the carcinogens. However, following the
identification ofa diolepoxide as the probable
ultimate carcinogen derived from benzo(a)
pyrene, considerable advances in the under-
standing of structure-activity relationships
were achieved. The nature of the hydro-
carbon-DNA products has been established
and the relevance of mutagenesis in both
bacterial and mammalian cells to the process
of carcinogenesis has been investigated. The
availability of geometrical isomers of the
proposed ultimate carcinogenic metabolites,
having clearly different biological activities,
has provided a powerful method of assessing
the relevance of various reaction products to
the process of carcinogenesis. Recently this
approach has been strengthened by the
realization that even stereoisomers differ in
their potency both as carcinogens and as
mutagens.
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